首页 | 本学科首页   官方微博 | 高级检索  
     

三种抗高血压药物治疗方案经济学及依从性评估
引用本文:岳德永,高恒荣,杨忠英,龚海燕,施志红. 三种抗高血压药物治疗方案经济学及依从性评估[J]. 药物流行病学杂志, 2010, 0(6): 336-339
作者姓名:岳德永  高恒荣  杨忠英  龚海燕  施志红
作者单位:[1]上海交通大学医学院附属新华医院崇明分院药剂科,上海202150 [2]复旦大学附属华山医院宝山分院临床药学室,上海202150
摘    要:目的:评价3种治疗高血压病方案的经济性和依从性。方法:210例原发性高血压患者随机分成3组,分别给与3种不同治疗方案,治疗过程中用问卷调查及随访表形式,量化患者依从性情况;治疗6个月,观察临床疗效,运用药物经济学的成本-效果分析方法进行评价。结果:3种方案有效率分别为90.0%、88.6%、82.9%;成本分别为752.64、903.26、287.84元。通过调查与随访,A组患者依从性最佳。结论:高血压病的医院治疗应科学选用治疗药物。为患者制定经济、合理、安全、有效的治疗方案。综合考虑,A组为最佳治疗方案。

关 键 词:原发性高血压  药物经济学  治疗方案  服药依从性  成本-效果分析

Assessment of the Compliance and Pharmacoeconomics of Three Therapeutic Regiments for Hypertension
Yue Deyong,Gao Hengrong,Yang Zhongying,Gong Haiyan,Shi Zhihong. Assessment of the Compliance and Pharmacoeconomics of Three Therapeutic Regiments for Hypertension[J]. Chinese Journal of Pharmacoepidemiology, 2010, 0(6): 336-339
Authors:Yue Deyong  Gao Hengrong  Yang Zhongying  Gong Haiyan  Shi Zhihong
Affiliation:1. Department of Pharmacy, Chongming Branch, Xinhua Hospital Affiliated to School of Medicine, Shanghai Jiaotong University, Shanghai 202150, China;2. Clinical Pharmaceutical Office, Baoshan Branch, Huashan Hospital Affiliated to Fudan University)
Abstract:Objective: To compare the pharmacoeconomics effects and drug compliance. Method: 210 cases of patients with essential hypertension were randomly divided into 3 groups ( P 〉 0.05 ). 3 different treatment programs were respectively worked out for them. During the treatment, questionnaire surveys and follows-up were carried out, and the compliance situations of the patients were quantified. The course of treatment was six months, and at the same time, their clinical efficacies were observed and the cost-effectiveness analysis of pharmacoeconomics was employed to evaluate the programs. Result: The efficiencies of the 3 programs were 90.0%, 88.6% and 82.9%, respectively and their costs were RMB 752.64, 903.26 and 287.84. The patients in Group A had the best compliance through investigations and followsup. Conclusion:The hospital should scientifically select therapeutic drugs in the treatment of hypertension so that we can develop economic, reasonable, safe and effective treatment programs for patients. Through the cost-effectiveness analysis, patients'drug compliance measuring and so on, the Group A program was the best treatment program.
Keywords:Essential hypertension  Pharmacoeconomics  Therapeutic programs  Drug compliance  Cost-effectiveness analysis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号